Most marketing measurement models operate on a simple assumption: effects are additive. Campaign A drives 100 leads, Campaign B drives 200, so the total impact is 300. But in reality, marketing often ...
Spexis AG has released results from an in vitro study evaluating the effects of combining its potent CXCR4 inhibitor balixafortide (BLX) with several available conventional or targeted therapies in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback